Genetic component for 40 percent of phenotypes studied; 25 percent have environmental risk factors
TUESDAY, Jan. 15, 2019 (HealthDay News) — The influence of heritability and environmental factors has been identified for a large number of phenotypes, according to a study published online Jan. 14 in Nature Genetics.
Chirag M. Lakhani, Ph.D., from Harvard Medical School in Boston, and colleagues examined the genetic and environmental contributions of 560 disease-related phenotypes in 56,396 twin pairs and 724,513 sibling pairs living in the United States. The contribution of environmental risk factors was estimated in each phenotype.
The researchers found that nearly 40 and 25 percent of the phenotypes studied had a genetic component and were driven at least in part by environmental risk factors, respectively. The greatest degree of heritability was seen for cognitive disorders (four of five diseases), while the lowest degree of genetic influence was seen for connective tissue disorders (two of 11). The highest degree of environmental influence was seen for eye disorders (effect seen for 27 of 42 diseases) and respiratory disorders (34 of 48); the lowest degree of environmental influence was seen for reproductive (three of 18) and cognitive disorders (two of five).
“Our results provide a comprehensive picture of the contribution of genetics and the environment to a large number of phenotypes,” the authors write. “Our estimates provide a useful baseline for determining the potential of further genetic and/or epidemiological research for a number of phenotypes of clinical relevance, applicable and complementary to precision medicine efforts.”
Abstract/Full Text (subscription or payment may be required)
Congenital Ichthyosis Linked to Allergic Disorders
Gene Mutation Identified That Increases Lung Cancer Risk
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50
Family History of CRC Increases CRC Risk Similarly in IBD, General Population
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Relapse Rare After Appendiceal Adenocarcinoma Resection